FDA Drug Safety Communication:

FDA warns about increased risk of serious pancreatitis with irritable bowel drug Viberzi (eluxadoline) in patients without a gallbladder.

If you are currently taking the medication prescribed at our office, Viberzi, (Eluxadoline) and you have had your gallbladder removed, you need to stop taking the medication.  The FDA has reported an increase risk of serious pancreatitis resulting in hospitalization. 

Any patient on the medication should not drink alcohol while on the medication.  If you are experiencing symptoms or are concerned you may call our office, at 912-303-4200, or learn more at https://www.fda.gov/Drugs/DrugSafety/ucm546154.htm